Free Trial

Pliant Therapeutics (PLRX) Insider Trading & Ownership

$12.73
-0.67 (-5.00%)
(As of 05/24/2024 ET)

Pliant Therapeutics (NASDAQ:PLRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.40%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$3.47 M
Get PLRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Pliant Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

PLRX Insider Buying and Selling by Quarter

Pliant Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/17/2024Bernard CoulieCEOSell25,721$17.23$443,172.83  
1/17/2024Hans HullInsiderSell9,786$17.23$168,612.78  
1/17/2024Keith Lamont CummingsCFOSell9,781$17.23$168,526.63  
1/17/2024Mike OuimetteGeneral CounselSell5,197$17.23$89,544.31  
8/3/2023Hans HullInsiderSell13,069$20.00$261,380.00  
7/20/2023Mike OuimetteGeneral CounselSell4,755$17.55$83,450.25  
7/17/2023Bernard CoulieCEOSell70,150$18.01$1,263,401.50  
7/17/2023Eric LefebvreInsiderSell22,321$18.01$402,001.21  
7/17/2023Keith Lamont CummingsCFOSell19,771$18.01$356,075.71  
7/17/2023Mike OuimetteGeneral CounselSell12,778$18.01$230,131.78  
(Data available from 1/1/2013 forward)

PLRX Insider Trading Activity - Frequently Asked Questions

Who is on Pliant Therapeutics's Insider Roster?

The list of insiders at Pliant Therapeutics includes Bernard Coulie, Eric Lefebvre, Hans Hull, Keith Lamont Cummings, and Mike Ouimette. Learn more on insiders at PLRX.

What percentage of Pliant Therapeutics stock is owned by insiders?

6.40% of Pliant Therapeutics stock is owned by insiders. Learn more on PLRX's insider holdings.

Which Pliant Therapeutics insiders have been selling company stock?

The following insiders have sold PLRX shares in the last 24 months: Bernard Coulie ($6,608,558.89), Eric Lefebvre ($3,420,810.31), Hans Hull ($429,992.78), Keith Lamont Cummings ($2,022,922.84), and Mike Ouimette ($1,440,137.19).

How much insider selling is happening at Pliant Therapeutics?

Insiders have sold a total of 568,015 Pliant Therapeutics shares in the last 24 months for a total of $13,922,422.01 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:PLRX) was last updated on 5/25/2024 by MarketBeat.com Staff

From Our Partners